Delivery Order SPE2DB20D1004-SPE2DB24FF3U1
Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The contract has a potential value of $3,138.17 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will be delivering the pharmaceutical product from its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $2,128.13 for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $1,699.17 firm fixed price contract is for the supply of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen holds as the primary vehicle to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $2,168.04 to provide TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. This contract has a period of performance through February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $2,999.56 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order is for the supply of the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S. This award is part of Amerisourcebergen Drug Corp's prime contract with DLA, an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $3,264.64 award has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical and medical supplies to U.S. government agencies, primarily the Department of Defense,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564147460 - TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award, valued at $7,194.39, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trelegy Ellipta 100-62.5-25 60S pharmaceutical product. The award, valued at $9,144.90, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is a child of a larger indefinite delivery contract (IDC) with a potential value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The $2,184.04 firm fixed price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF3U1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract performance period runs through February 7, 2024.
Generated 5/7/24, 11:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/6/24 |